Price movement over the last 24 hours
Align Technology, Inc. vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while iShares 1 3 Year Treasury Bond ETF trades at $81.89. The key difference: Align Technology, Inc. is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | SHY | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Fixed Income |
52-Week High | $207.19 | $83.18 |
52-Week Low | $124.88 | $81.84 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
SHY trades at $81.88, down 0.04% with a bearish technical signal from moving averages. The ETF shows neutral momentum oscillators and uniform support/resistance at $82. Recent corporate actions include scheduled dividends of $0.24 per share through mid-2026, providing income stability amid flat price movement.
Outlook remains cautious due to technical bearishness and interest rate sensitivity. Opportunities include consistent dividend yields, while risks involve Federal Reserve policy shifts impacting bond ETFs. Investors should weigh income benefits against potential rate hike volatility in the fixed income sector.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →